Catalyst Capital Advisors LLC increased its position in shares of HCA Healthcare Inc (NYSE:HCA) by 44.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 22,320 shares of the company’s stock after purchasing an additional 6,880 shares during the period. Catalyst Capital Advisors LLC’s holdings in HCA Healthcare were worth $1,961,000 at the end of the most recent quarter.
Other institutional investors have also recently added to or reduced their stakes in the company. Virtu KCG Holdings LLC purchased a new position in HCA Healthcare during the second quarter worth about $312,000. Janus Henderson Group PLC boosted its stake in HCA Healthcare by 745.0% during the second quarter. Janus Henderson Group PLC now owns 347,905 shares of the company’s stock worth $30,336,000 after buying an additional 306,732 shares during the period. Verition Fund Management LLC purchased a new position in HCA Healthcare during the second quarter worth about $516,000. Dynamic Technology Lab Private Ltd purchased a new position in HCA Healthcare during the second quarter worth about $444,000. Finally, Toronto Dominion Bank boosted its stake in HCA Healthcare by 23.5% during the second quarter. Toronto Dominion Bank now owns 99,913 shares of the company’s stock worth $8,710,000 after buying an additional 19,038 shares during the period. Hedge funds and other institutional investors own 75.49% of the company’s stock.
In related news, insider Michael S. Cuffe sold 8,335 shares of HCA Healthcare stock in a transaction that occurred on Friday, February 9th. The shares were sold at an average price of $97.26, for a total value of $810,662.10. Following the completion of the transaction, the insider now owns 26,089 shares in the company, valued at $2,537,416.14. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Victor L. Campbell sold 8,000 shares of HCA Healthcare stock in a transaction that occurred on Thursday, November 16th. The stock was sold at an average price of $75.82, for a total transaction of $606,560.00. Following the completion of the transaction, the senior vice president now owns 127,275 shares of the company’s stock, valued at approximately $9,649,990.50. The disclosure for this sale can be found here. Insiders sold 284,469 shares of company stock valued at $28,208,384 in the last quarter. 2.90% of the stock is owned by insiders.
HCA Healthcare Inc (NYSE HCA) opened at $98.92 on Wednesday. The company has a quick ratio of 1.36, a current ratio of 1.62 and a debt-to-equity ratio of -6.58. HCA Healthcare Inc has a 12 month low of $71.18 and a 12 month high of $106.84. The company has a market cap of $35,730.00, a P/E ratio of 16.65, a PEG ratio of 0.98 and a beta of 0.48.
HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Tuesday, January 30th. The company reported $2.12 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.87 by $0.25. HCA Healthcare had a net margin of 4.89% and a negative return on equity of 49.49%. The business had revenue of $11.56 billion during the quarter, compared to analyst estimates of $11.19 billion. During the same quarter last year, the firm posted $1.80 earnings per share. The business’s revenue for the quarter was up 8.7% compared to the same quarter last year. sell-side analysts expect that HCA Healthcare Inc will post 8.71 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 30th. Stockholders of record on Thursday, March 1st will be paid a $0.35 dividend. This represents a $1.40 annualized dividend and a dividend yield of 1.42%. The ex-dividend date of this dividend is Wednesday, February 28th.
Several research analysts have weighed in on HCA shares. Credit Suisse Group reaffirmed an “outperform” rating and set a $25.00 target price on shares of HCA Healthcare in a research note on Tuesday, December 26th. Robert W. Baird set a $104.00 target price on shares of HCA Healthcare and gave the stock a “buy” rating in a research note on Friday, January 12th. Raymond James Financial lowered shares of HCA Healthcare from a “strong-buy” rating to a “market perform” rating in a research note on Wednesday, October 18th. Morgan Stanley lowered shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $85.00 target price for the company. in a research note on Wednesday, December 20th. Finally, Goldman Sachs Group started coverage on shares of HCA Healthcare in a research note on Wednesday, January 3rd. They set a “neutral” rating for the company. Three research analysts have rated the stock with a sell rating, six have assigned a hold rating and eighteen have given a buy rating to the company. The stock presently has an average rating of “Buy” and an average price target of $104.50.
ILLEGAL ACTIVITY WARNING: “HCA Healthcare Inc (HCA) Position Raised by Catalyst Capital Advisors LLC” was first posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this piece of content on another website, it was illegally copied and reposted in violation of U.S. and international trademark and copyright law. The original version of this piece of content can be viewed at https://www.dispatchtribunal.com/2018/02/14/hca-healthcare-inc-hca-position-raised-by-catalyst-capital-advisors-llc.html.
About HCA Healthcare
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.